The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Medicinal cannabis no different than placebo for painful diabetic neuropathy

    marijuana leafResearchers from Royal Hallamshire Hospital, in Sheffield, UK studied Sativex, a cannabis based medicinal extract.

    First, the details.

    • 30 people with painful-diabetic peripheral neuropathy were assigned to a treatment group.
      • Sativex or placebo

    And, the results.

    • Both treatments showed significant improvement in pain scores, but there was no difference between treatment groups.
    • There was also no difference in quality of life.

    The bottom line?
    Patients with depression had significantly greater pain scores at the start of treatment, which improved regardless of treatment.

    The authors think that this might have important implications for future studies.

    A PubMed search revealed no other similar studies in humans.

    10/27/09 21:40 JR

    Leave a Comment

    You must be logged in to post a comment.